Amneal Pharmaceuticals has voluntarily recalled 858 bottles of Phenoxybenzamine Hydrochloride Capsules (10mg), a prescription medication used to manage certain blood pressure conditions. The recall was initiated because testing detected an unknown impurity that does not meet required safety and degradation specifications. No injuries or adverse events have been reported in connection with this recall.
The presence of unknown impurities in medication can lead to unpredictable side effects or may reduce the effectiveness of the drug in managing blood pressure. While no specific incidents have been reported, the medication no longer meets the strict quality standards required for safe use.
You have 2 options:
Rx only; Manufactured by Amneal Pharmaceuticals Pvt. Ltd in India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.